A patient-derived study linked tumor-secreted extracellular vesicles to macrophage immune reprogramming in prostate cancer via a miR-302/367 microRNA axis. Researchers reported that liquid biopsy samples from patients undergoing diagnostic workup carried miR-302/367 cluster–enriched vesicles that shifted monocyte-derived macrophages toward an M2-like, immunoregulatory state. Mechanistically, functional inhibition of miR-302a-5p and miR-367-3p restored M1-like inflammatory and antigen-presenting features in macrophages across prostate-cancer grades tested, while sparing macrophages from biopsy-negative controls. The team further showed that blocking the microRNAs within vesicles promoted pro-inflammatory polarization. The study also found the macrophage phenotype associated with histological grade, supporting a clinical correlation even though the experiments were not designed to prove the miRNA activity causes grade progression. Still, the work identifies a circulating signaling pathway that can connect tumor biology to systemic myeloid conditioning. For the field, it advances the concept that liquid biopsy signals are not just correlative biomarkers; they may reflect functional cross-talk that could be leveraged for combination strategies or stratified immune monitoring.